Eziclen

Leaflet attached to the packaging: patient information

Warning! Keep the leaflet! Information on the immediate packaging in a foreign language.

Eziclen (Izinova)

(17,510 g + 3,276 g + 3,130 g)/bottle, concentrate for oral solution preparation
Anhydrous sodium sulfate + Heptahydrate magnesium sulfate + Potassium sulfate
Eziclen and Izinova are different trade names for the same drug.

You should carefully read the contents of the leaflet before taking the medicine, as it contains important information for the patient.

• You should keep this leaflet so that you can read it again if necessary.
• In case of any doubts, you should consult a doctor or pharmacist.
• This medicine has been prescribed specifically for you. Do not pass it on to others. The medicine may harm another person, even if their symptoms are the same.
• If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. See section 4.

Table of contents of the leaflet:

• 1. What is Eziclen and what is it used for
• 2. Important information before taking Eziclen
• 3. How to take Eziclen
• 4. Possible side effects
• 5. How to store Eziclen
• 6. Contents of the packaging and other information

1. What is Eziclen and what is it used for

Eziclen contains three different active substances: sodium sulfate, magnesium sulfate, and potassium sulfate.
Eziclen is used in adults to cleanse the intestine before a medical examination or surgical procedure on the intestine.
Eziclen is not a laxative.
Eziclen must be diluted with water before use, in the amount specified in the administration method (see section 3).

2. Important information before taking Eziclen

When not to take Eziclen:

• If the patient is allergic to sodium sulfate, magnesium sulfate, or potassium sulfate, or any of the other ingredients of this medicine (listed in section 6).
• If the patient has severe heart problems (congestive heart failure).
• If the patient has severe general health impairment, such as severe dehydration.
• If the patient has acute phases of active inflammatory bowel disease (including Crohn's disease and ulcerative colitis).
• If the patient has any of the following stomach or intestinal disorders:
• known or suspected intestinal obstruction or narrowing
• toxic megacolon or toxic colonic dilation
• diagnosed or suspected intestinal wall perforation
• intestinal paralysis
• gastric emptying problems (e.g., gastric paralysis, gastric stasis)
• acute abdominal conditions requiring surgery, such as acute appendicitis
• nausea and vomiting.
• If the patient has ascites.
• If the patient has severe kidney function disorders (severe renal failure).

In case of doubts, you should consult your doctor before taking Eziclen.

Warnings and precautions

Before starting Eziclen, you should consult your doctor if:

• The patient is dehydrated (symptoms may include dry mouth, thirst, headache, dizziness, urinating less often than usual, extreme fatigue, heart palpitations, and confusion)
• The patient has ever had abnormal sodium or potassium levels in the blood
• The patient has heart disease. Eziclen may affect heart rhythm due to changes in blood salt levels. Monitoring of the patient during treatment may be necessary.
• The patient has kidney disease (renal failure)
• Dehydration can cause kidney function disorders (renal failure), which are reversible with proper treatment
• The patient has liver disease
• The patient has disorders related to "uric acid" (gout or other diseases)
• The patient has swallowing disorders
• The patient has "reflux" when stomach acid is thrown back into the esophagus
• The patient is physically weakened or in poor health
• The patient has weakened intestinal function (weakened peristalsis)
• The patient has a history of health conditions or surgical procedures related to the digestive tract, predisposing to weakened peristalsis of the digestive tract.

If the patient is weakened or elderly (65 years or older), has severe kidney, liver, or heart disease, or is at risk of changes in salt levels in the body (electrolyte disorders), the doctor may recommend special monitoring of the patient before and after the examination or procedure. The patient should pay special attention to the recommendations listed in this part of the leaflet as well as in the "Other medicines and Eziclen" and "How to take Eziclen" sections.
If the patient experiences severe vomiting or symptoms of dehydration (e.g., dry mouth, thirst) after taking this medicine, they should inform their doctor, who will recommend the use of hydrating measures.
If severe or persistent abdominal pain and/or rectal bleeding occur after taking Eziclen, the patient should consult their doctor. During the use of Eziclen, there have been rare cases of colitis (colonic inflammation).
If any of the above points apply to the patient (or in case of uncertainty), they should consult their doctor before taking Eziclen.
After taking the medicine, frequent loose stools will occur. This is normal and indicates the effective action of the medicine. The patient should stay near a toilet until the effect of the medicine subsides.
The patient should strictly follow the recommendations and drink as much water or clear fluids as needed to avoid dehydration.
Children and adolescents
Eziclen is not intended for use in patients under 18 years of age. The safety and efficacy of this medicine in this patient group have not been established.

Other medicines and Eziclen

The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take .This includes over-the-counter medicines and herbal products.
If the patient is taking any other medicines, they should take them one to three hours before taking Eziclen or at least one hour after completing the bowel cleansing process. This is because the diarrhea caused by Eziclen may flush out other medicines from the body, making them less effective.
Special precautions should be taken in the case of:

• medicines that may affect fluid or salt levels in the blood (such as diuretics, calcium channel blockers, or lithium salts) or medicines that affect heart rhythm.
• oral medicines taken regularly, such as oral contraceptives, antiepileptics, antidiabetics, antibiotics, levothyroxine (a hormone used to treat hypothyroidism), or digoxin (used in heart conditions), as Eziclen may delay or completely inhibit the absorption of these medicines, reducing or eliminating their effect.

Pregnancy and breastfeeding

If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
During breastfeeding, the patient should not breastfeed their child for 48 hours after taking the second dose of Eziclen.

Driving and using machines

Eziclen is unlikely to affect the ability to drive or use tools or machines.

Eziclen contains sodium and potassium

If the patient is on a controlled salt diet (sodium or potassium), they should note that each bottle of Eziclen contains 5.684 g (247.1 mmol) of sodium and 1.405 g (35.9 mmol) of potassium.

3. How to take Eziclen

This medicine should always be taken exactly as described in this patient leaflet or as directed by the doctor. In case of doubts, the patient should consult their doctor or pharmacist.

Administration

• The medicine should be taken orally.
• The day before the examination or procedure, the patient can have a light breakfast. After breakfast, they should only drink clear fluids for lunch, dinner, and any other meals until the examination or procedure. The patient should not drink red or purple beverages, milk, or alcoholic beverages.
• Eziclen is supplied in 2 bottles packed in a box with a measuring cup for dilution and administration of the medicine. All these elements are necessary for the administration of the medicine.
• Do notdrink the contents of both bottles at the same time.
• Do notdrink the contents of the bottles before diluting them.
• Do notforget to drink an additional amount of water or allowed clear fluids.
• The doctor will provide the patient with a form to record the time of starting treatment and the amount of fluids taken during the preparatory bowel cleansing. The patient should strictly follow the recommendations and drink as much water or clear fluids as needed to avoid dehydration.
• “Clear fluids” include water, tea, or coffee (without milk or non-dairy creamer), carbonated or non-carbonated drinks, strained fruit juices without pulp (of any color other than red or purple), clear soup or soup strained to remove all solid elements.
  The patient should not drink alcoholic beverages.

  How and when to take this medicine

  Eziclen can be taken in a "Two-Day" or "One-Day" scheme. The doctor will decide which scheme and at what time the medicine should be taken.

  • In the case of an examination or procedure without general anesthesia, the patient should stop drinking fluids at least one hour before the examination or procedure.
  • In the case of an examination or procedure with general anesthesia, the patient should stop drinking fluids usually at least two hours before the examination or procedure, following the anesthesiologist's instructions.
  • Two-Day schemeThe dosage is divided into the evening of the day before the examination or procedure and the morning of the day of the examination or procedure. The day before the examination or procedure:
  • take the first part of the scheme (first bottle) in the early evening (i.e., no later than 6:00 PM). On the day of the examination or procedure:
  • take the second part of the scheme (second bottle) in the early morning, 10 to 12 hours after starting the first part of the scheme (first bottle)
  • One-Day schemeThe dosage starts and ends in the evening of the day before the examination or procedure. The day before the examination or procedure:
  • take the first part of the scheme (first bottle) in the early evening (i.e., no later than 6:00 PM)
  • take the second part of the scheme (second bottle) about 2 hours after starting the first part of the scheme (first bottle)

  Regardless of the scheme chosen by the doctor, the following steps should be performed for the first and second parts of the scheme:

  • 1) Open the child-resistant bottle by pressing the cap and turning it in the opposite direction to the clockwise direction.
  

  by pressing the cap and turning it in the opposite direction to the clockwise direction.

  • 2) Pour the contents of one Eziclen bottle into the cup.
  
  • 3) Add water to the medicine up to the mark on the cup.
  
  • 4) Drink the entire contents of the cup without rushing (within half an hour to one hour).
  • 5) IMPORTANT INFORMATION: Drink two (2) additional cups of water or
  

  clear fluid. Each time, fill the cup with water or clear fluid up to the mark.

  • 6) Drink the entire contents of each cup without rushing (within half an hour).
  

  The performance of the steps listed in points 1 to 6 takes about 2 hours and should be repeated for the second part of the scheme.
  Regardless of the scheme used, the patient should stop drinking fluids:

  • at least one hour before the examination or procedure, in the case of an examination or procedure without general anesthesia,
  • usually at least two hours before the examination or procedure, in the case of an examination or procedure with general anesthesia, following the anesthesiologist's instructions.

  Overdose of Eziclen

  • If the patient thinks they have taken too much Eziclen or have not diluted the medicine as recommended, or have not drunk enough additional water, they should inform their doctor and drink enough water or clear fluids to avoid dehydration.

  Missed dose of Eziclen

  • In case of a missed dose, the patient should contact their doctor as soon as possible, as this may mean that the medicine will not work as expected. In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.

  4. Possible side effects

  In case of rectal bleeding during or after colonoscopy preparation, the patient should contact their doctor.
  Like all medicines, Eziclen can cause side effects, although not everybody gets them.
  The following side effects may occur when taking this medicine:

  If the patient experiences any of the following symptoms, they should stop taking Eziclen and consult their doctor immediately:

  • Allergic reaction - symptoms may include skin rash or redness, itching, difficulty breathing, or throat swelling.

  Other side effects include:

  Very common (may affect more than 1 in 10 people)

  • General discomfort
  • Nausea or vomiting
  • Bloating or stomach pain.

  Uncommon (may affect up to 1 in 100 people)

  • Chills
  • Dry mouth
  • Headache
  • Dizziness
  • Pain when urinating
  • Discomfort in the anal or rectal area
  • Changes in the levels of certain blood components. Examples include: increased activity of "aspartate aminotransferase", "creatine phosphokinase", "lactate dehydrogenase", increased levels of "phosphates", "bilirubin", or "uric acid", and decreased levels of "sodium", "potassium", or "calcium".

  Frequency not known (frequency cannot be estimated from the available data):

  Intestinal ulcers or disorders (ischemic colitis). The patient should immediately tell their doctor if they experience severe stomach pain or rectal bleeding.

  • Dehydration, changes in blood salt levels, fatigue, trembling, sweating, heart palpitations, loss of consciousness (seizures), disorientation, muscle cramps.

  Reporting side effects

  If the patient experiences any side effects, including any side effects not listed in the leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
  By reporting side effects, more information can be collected on the safety of the medicine.

  5. How to store Eziclen

  • The medicine should be stored out of sight and reach of children.
  • Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated.
  • There are no special storage temperature recommendations for the medicine.
  • Store in the original packaging to protect from light.
  • After opening the bottle and/or diluting the contents with water, the solution should be used immediately.
  • Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.

  6. Contents of the packaging and other information

  What Eziclen contains

  • The active substances are: anhydrous sodium sulfate, heptahydrate magnesium sulfate, and potassium sulfate. Each bottle of approximately 176 ml of concentrate contains 17.510 g of anhydrous sodium sulfate, 3.276 g of heptahydrate magnesium sulfate, and 3.130 g of potassium sulfate. The total electrolyte content is as follows:

  Content in g
  Content in mmol
  1 bottle
  2 bottles
  1 bottle
  2 bottles
  Sodium*
  5.684
  11.367
  247.1
  494.42
  Potassium
  1.405
  2.81
  35.9
  71.8
  Magnesium
  0.323
  0.646
  13.3
  26.6
  Sulfates
  14.845
  29.69
  154.5
  309.0
  * derived from sodium sulfate (active substance) and sodium benzoate (excipient).
  The other ingredients are sodium benzoate (E 211), citric acid, sucralose, malic acid, purified water, and fruit cocktail flavor [a mixture of natural and synthetic flavorings, propylene glycol (E 1520), ethanol, acetic acid, and benzoic acid (E 210)].

  What Eziclen looks like and what the pack contains

  • The medicine is a concentrate for oral solution preparation, and the concentrate is clear or slightly cloudy.
  • It is supplied in 2 bottles of approximately 176 ml each, packed in a box with a cup, with a volume of approximately half a liter, for dilution and administration of the medicine.
  • Available pack sizes:
  • 1 pack containing two bottles and one cup.

  For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.

  Marketing authorization holder in France, the country of export:

  Ipsen Consumer HealthCare
  65, quai Georges Gorse
  92100 Boulogne Billancourt
  France

  Manufacturer:

  Beaufour Ipsen Industrie
  Rue Ethé Virton
  28100 Dreux
  France

  Parallel importer:

  InPharm Sp. z o.o.
  ul. Strumykowa 28/11
  03-138 Warsaw

  Repackaged by:

  Pharma Innovations Sp. z o.o.
  ul. Jagiellońska 76
  03-301 Warsaw
  InPharm Sp. z o.o. Services sp. k.
  ul. Chełmżyńska 249
  04-458 Warsaw
  Marketing authorization number in France, the country of export:269 952-4
  34009 269 952 4 9
  Parallel import authorization number:364/19

  Date of leaflet approval: 25.09.2024

  [Information about the trademark]